CytomX Therapeutics Cash Flow Statement (2014-2025) | CTMX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-23.33M	-26.74M	-30.98M	-34.82M	-31.98M	-29.50M	-29.06M	-8.78M	-3.31M	-1.09M	2.99M	0.84M	13.79M	-6.53M	5.74M	18.88M	23.52M	-0.15M	-14.23M	-26.51M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	3.03M	3.42M	3.16M	3.54M	3.37M	2.40M	0.10M	-9.55M	2.41M	0.50M	0.50M	2.55M	1.91M	0.40M	2.00M	1.88M	0.50M	0.20M	0.60M	1.48M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)							0.19M	0.19M	0.11M		0.10M	0.22M	0.71M	0.71M	0.12M	0.12M	0.52M	0.28M	0.53M	0.57M
Gains from Investment Securities (Quarter)	11.86M	3.63M	4.11M	12.19M	0.43M	1.08M	14.26M	13.29M	1.15M	0.85M	13.29M	12.95M	14.31M	14.51M	2.37M	14.56M	16.78M	6.30M	0.41M	2.19M
Non-cash Items (Quarter)	5.34M	5.74M	5.71M	6.05M				14.25M				8.67M				10.57M				11.35M
Cash from Operations (Quarter)	-29.94M	-28.20M	-29.70M	-31.19M	-41.31M	-34.24M	-33.84M	-1.39M	9.35M	-25.18M	-18.24M	-21.96M	-26.05M	-19.55M	-20.73M	-19.91M	-21.04M	-15.75M	-15.55M	-23.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.14M	-0.14M	-0.01M	0.43M	0.02M	0.06M	-0.03M	0.01M	1.53M	-1.46M	0.04M	-0.01M	1.87M	-1.79M	4.45M	-4.38M	0.04M	0.04M	0.04M	0.04M
Depreciation & Amortization (CF) (Quarter)	0.64M	0.64M	0.64M	0.64M	0.56M	0.57M	0.59M	0.57M	0.56M	0.57M	0.45M	0.45M	0.43M	0.42M	0.39M	0.38M	0.35M	0.31M	0.10M	0.47M
Change in Working Capital
Change in Receivables (Quarter)	-0.04M	0.17M	-0.04M	-0.10M	0.23M	0.06M	0.70M	34.21M	-34.90M	0.81M	0.52M	1.01M	9.74M	-10.40M	0.58M	-0.25M	-1.15M	-0.09M	-0.24M	0.38M
Change in Account Payables (Quarter)	-0.29M	-0.88M	-0.18M	1.22M	-1.06M	0.22M	3.29M	-2.37M	-0.62M	-1.16M	0.68M	-0.33M	0.58M	-1.43M	0.81M	-0.26M	-0.80M	-0.05M	0.42M	0.66M
Change in Accured Expenses (Quarter)	-5.10M	-0.46M	5.01M	8.11M	-4.18M	-0.30M	-1.41M	-3.89M	-7.36M	-3.12M	2.01M	1.42M	-4.43M	-1.67M	2.03M	-5.55M	-2.11M	-1.10M	-0.33M	0.49M
Other Working Capital Changes (Quarter)	-7.44M	-7.87M	-8.30M	20.80M	0.00M	-19.86M	19.86M	16.57M	-17.41M	-22.76M	-24.50M	62.25M	-28.94M	-22.89M	50.07M	0.34M	-44.62M	45.70M	-0.71M	-65.96M
Investing Activities
Capital Expenditures (Quarter)	0.98M	-0.93M	1.31M	0.24M	0.74M	0.41M	0.41M	0.18M	0.05M	0.52M	0.01M	-0.50M	0.01M	0.20M	0.02M	-0.22M		0.15M	-0.13M	-0.02M
Change in Acquisitions & Divestments (Quarter)	59.99M	54.00M	10.00M					100.00M		100.00M	50.00M	125.00M	45.00M	115.00M	30.50M	65.00M	50.50M	32.50M	20.00M	30.00M
Cash from Investing Activities (Quarter)	59.01M	-46.01M	9.73M	-0.24M	-0.74M	-0.41M	-0.41M	99.82M	-146.64M	26.04M	-42.94M	12.87M	44.88M	21.51M	18.17M	15.13M	30.60M	-76.36M	0.44M	-14.42M
Financing Activities
Cash from Financing Activities (Quarter)	108.73M	0.69M	0.10M	0.68M	0.01M	0.45M		0.19M		0.32M	29.67M	0.24M	0.17M	5.10M		2.25M		93.55M	0.25M	16.64M
Additional items
Change in Cash (Quarter)	137.81M	-73.52M	-19.86M	-30.75M	-42.04M	-34.20M	-34.26M	98.61M	-137.29M	1.18M	-31.51M	-8.85M	19.01M	7.06M	-2.56M	-2.52M	9.55M	1.44M	-14.86M	-21.02M
Free Cash Flow (Quarter)	-30.92M	-27.27M	-31.01M	-31.44M	-42.05M	-34.65M	-34.26M	-1.57M	9.30M	-25.70M	-18.25M	-21.46M	-26.05M	-19.75M	-20.75M	-19.69M	-21.04M	-15.90M	-15.42M	-23.22M
Net Cash Flow (Quarter)	137.81M	-73.52M	-19.86M	-30.75M	-42.04M	-34.20M	-34.26M	98.61M	-137.29M	1.18M	-31.51M	-8.85M	19.01M	7.06M	-2.56M	-2.52M	9.55M	1.44M	-14.86M	-21.02M

Research Tools

CytomX Therapeutics Cash Flow Statement (2014-2025) | CTMX

Create an account

Sign In

Reset Password